Observational studyBMC cancer2019

Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.

Semjon Willier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.